Although many studies manipulated PV interneurons in Alzheimer’s disease studies [5, 7, 8], our study is the first to directly show how manipulation of SST interneurons could alleviate Alzheimer’s disease-related dysfunctions. This evidence concerns the gene SST and early-onset autosomal dominant Alzheimer disease.